The optimal treatment of hemophilia has been evolving since the advent of factor VIII concentrates, continues to vary geographically, and remains a source of debate...
Keywords: Hemophilia, prophylaxis, on-demand, factor VIII, arthropathy, cost-benefit
10/2006 | Thrombosis and Haemostasis, SchattauerAcutely dyspneic patients are challenging, because their symptoms can be due to cardiac, pulmonary or other diseases...
Keywords: acute heart failure, B-type natriuretic peptides, cost-benefit, diagnostic gray zone, Prognosis
11/2008 | Clinical Chemical Laboratory Medicine, Walter de Gruyter